Skip to main content
All lobbying filings

KYLE HOUSE GROUP

Lobbying for US PHARMACOPEIA · Pharmaceutical manufacturing

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $20,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 1
  • HR 8595
    Making appropriations for national security, Department of State, and related programs for the fiscal year ending Septe…
 Lobbying activity 2
Foreign Relations

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027

Health Issues

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem